It just seemed that is where a lot of the prescriptions were coming, not everyone.
Editor's note · Context
Guthrie addresses the concentration of prescription drug issues in Medicaid.
Share & report
More from James Guthrie
There is no reason why we should continue to see Americans paying 2 to 3 times more for drugs here in America, when those same drugs are sold in other parts of the world for so much less.
Where we do not and we will never agree is on the idea that forcing companies to accept whatever price the government feels like paying for prescription medications is the correct way to lower the cost of prescription medications.
While transparency is necessary for a functioning market, there must also be competition to lower prices and increase quality.
As we turn the page on both 2022 and the 117th Congress, thousands of Americans and their families are still reeling from failures by this administration and the last Congress to meaningfully address one of the greatest public health threats of our lifetimes, the fentanyl crisis.





